Single-Domain Antibodies As Therapeutics against Human Viral Diseases

In full-size formats, monoclonal antibodies have been highly successful as therapeutics against cancer and immune diseases. However, their large size leads to inaccessibility of some epitopes and relatively high production costs. As an alternative, single-domain antibodies (sdAbs) offer special adva...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yanling, Jiang, Shibo, Ying, Tianlei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733491/
https://www.ncbi.nlm.nih.gov/pubmed/29326699
http://dx.doi.org/10.3389/fimmu.2017.01802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733491/
https://www.ncbi.nlm.nih.gov/pubmed/29326699
http://dx.doi.org/10.3389/fimmu.2017.01802

Ejemplares similares